Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone plus bleomycin vs triamcinolone alone for localized keloids
ChiCTR2600129979Phase 4Recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in keloid comparing Control: triamcinolone monotherapy with triamcinolone plus bleomycin (2 arms). Primary endpoint: Vancouver Scar Scale (VSS) score. Started Aug 2026; status: recruiting.
02
Drugs
triamcinolonebleomycin
03
Conditions
keloid
Beyond the preview
Go deeper on ChiCTR2600129979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129979.